NASDAQ:GENB

Generate Biomedicines, Inc.

Read GENB's Filings Free

Company facts

Most recent report
10-Q, filed Aug 6, 2026
Incorporated
Delaware
Filings on record
49 filings
On EDGAR
CIK 2100782
Fiscal year ends
December
Filer status
Emerging growth company

Everything here comes from Generate Biomedicines, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.